Mercury Laboratories [MERCURYLAB] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Mercury Laboratories

Divi's Laboratories
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Mercury Laboratories wins in 7 metrics, Divi's Laboratories wins in 13 metrics, with 0 ties. Divi's Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Mercury Laboratories | Divi's Laboratories | Better |
---|---|---|---|
P/E Ratio (TTM) | 26.09 | 65.37 | Mercury Laboratories |
Price-to-Book Ratio | 1.84 | 10.13 | Mercury Laboratories |
Debt-to-Equity Ratio | 10.18 | 0.03 | Divi's Laboratories |
PEG Ratio | 0.14 | 2.47 | Mercury Laboratories |
EV/EBITDA | 13.90 | 48.31 | Mercury Laboratories |
Profit Margin (TTM) | 4.93% | 23.89% | Divi's Laboratories |
Operating Margin (TTM) | 8.34% | 25.60% | Divi's Laboratories |
EBITDA Margin (TTM) | 8.34% | 25.60% | Divi's Laboratories |
Return on Equity | 5.87% | 14.64% | Divi's Laboratories |
Return on Assets (TTM) | 4.23% | 12.94% | Divi's Laboratories |
Free Cash Flow (TTM) | $-50.39M | $2.15B | Divi's Laboratories |
Dividend Yield | 0.82% | 0.91% | Divi's Laboratories |
1-Year Return | -17.07% | 8.12% | Divi's Laboratories |
Price-to-Sales Ratio (TTM) | 1.29 | 15.71 | Mercury Laboratories |
Enterprise Value | $1.02B | $1,480.60B | Divi's Laboratories |
EV/Revenue Ratio | 1.34 | 15.34 | Mercury Laboratories |
Gross Profit Margin (TTM) | 60.02% | 60.33% | Divi's Laboratories |
Revenue per Share (TTM) | $638 | $363 | Mercury Laboratories |
Earnings per Share (Diluted) | $31.43 | $87.36 | Divi's Laboratories |
Beta (Stock Volatility) | 0.57 | 0.18 | Divi's Laboratories |
Mercury Laboratories vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Mercury Laboratories | 3.66% | 3.84% | 1.80% | -0.74% | 1.18% | -4.50% |
Divi's Laboratories | 2.73% | 3.10% | -4.83% | -14.69% | 1.79% | -3.41% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Mercury Laboratories | -17.07% | 42.15% | 92.55% | 110.81% | 2,274.30% | 2,274.30% |
Divi's Laboratories | 8.12% | 57.02% | 83.89% | 435.51% | 1,516.65% | 7,132.15% |
News Based Sentiment: Mercury Laboratories vs Divi's Laboratories
Mercury Laboratories
News based Sentiment: MIXED
September presented a mixed bag for Mercury Laboratories, with a positive valuation upgrade countered by concerns over profitability and a declining share price over the past year. The volatility and conflicting signals make it a significant month for investors to assess the company's direction.
Divi's Laboratories
News based Sentiment: MIXED
September presented a mixed bag for Divi's Laboratories, with stellar FY25 results overshadowed by a weaker Q1 FY26 performance and fluctuating analyst opinions. The Nifty 50 exclusion adds another layer of complexity, creating a dynamic investment scenario that requires careful monitoring.
Performance & Financial Health Analysis: Mercury Laboratories vs Divi's Laboratories
Metric | MERCURYLAB | DIVISLAB |
---|---|---|
Market Information | ||
Market Cap | ₹1.02B | ₹1.61T |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 28 | 437,716 |
90 Day Avg. Volume | 138 | 381,180 |
Last Close | ₹850.00 | ₹5,866.00 |
52 Week Range | ₹736.00 - ₹1,190.00 | ₹4,955.00 - ₹7,071.50 |
% from 52W High | -28.57% | -17.05% |
All-Time High | ₹1,303.00 (Jan 08, 2024) | ₹7,071.50 (Jul 08, 2025) |
% from All-Time High | -34.77% | -17.05% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.09% | 0.14% |
Quarterly Earnings Growth | 1.83% | 0.27% |
Financial Health | ||
Profit Margin (TTM) | 0.05% | 0.24% |
Operating Margin (TTM) | 0.08% | 0.26% |
Return on Equity (TTM) | 0.06% | 0.15% |
Debt to Equity (MRQ) | 10.18 | 0.03 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹446.41 | ₹563.87 |
Cash per Share (MRQ) | ₹12.97 | ₹132.86 |
Operating Cash Flow (TTM) | ₹-12,625,000 | ₹19.67B |
Levered Free Cash Flow (TTM) | ₹31.45M | ₹21.91B |
Dividends | ||
Last 12-Month Dividend Yield | 0.82% | 0.91% |
Last 12-Month Dividend | ₹7.00 | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Mercury Laboratories vs Divi's Laboratories
Metric | MERCURYLAB | DIVISLAB |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 26.09 | 65.37 |
Forward P/E | N/A | 101.43 |
PEG Ratio | 0.14 | 2.47 |
Price to Sales (TTM) | 1.29 | 15.71 |
Price to Book (MRQ) | 1.84 | 10.13 |
Market Capitalization | ||
Market Capitalization | ₹1.02B | ₹1.61T |
Enterprise Value | ₹1.02B | ₹1.48T |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.34 | 15.34 |
Enterprise to EBITDA | 13.90 | 48.31 |
Risk & Other Metrics | ||
Beta | 0.57 | 0.18 |
Book Value per Share (MRQ) | ₹446.41 | ₹563.87 |
Financial Statements Comparison: Mercury Laboratories vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MERCURYLAB | DIVISLAB |
---|---|---|
Revenue/Sales | ₹181.35M | ₹24.10B |
Cost of Goods Sold | ₹72.50M | ₹9.56B |
Gross Profit | ₹108.85M | ₹14.54B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹15.12M | ₹6.17B |
EBITDA | ₹25.36M | ₹8.48B |
Pre-Tax Income | ₹15.47M | ₹7.33B |
Income Tax | ₹5.80M | ₹1.88B |
Net Income (Profit) | ₹9.68M | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MERCURYLAB | DIVISLAB |
---|---|---|
Cash & Equivalents | ₹3.32M | ₹4.15B |
Total Current Assets | ₹401.60M | ₹100.81B |
Total Current Liabilities | ₹150.76M | ₹14.52B |
Long-Term Debt | ₹37.83M | ₹20.00M |
Total Shareholders Equity | ₹535.69M | ₹149.69B |
Retained Earnings | ₹86.56M | ₹134.00B |
Property, Plant & Equipment | ₹85.40M | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MERCURYLAB | DIVISLAB |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | MERCURYLAB | DIVISLAB |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 28 | 437,716 |
Average Daily Volume (90 Day) | 138 | 381,180 |
Shares Outstanding | 1.20M | 265.47M |
Float Shares | 166,416 | 120.77M |
% Held by Insiders | 0.86% | 0.52% |
% Held by Institutions | 0.00% | 0.29% |
Dividend Analysis & Yield Comparison: Mercury Laboratories vs Divi's Laboratories
Metric | MERCURYLAB | DIVISLAB |
---|---|---|
Last 12-Month Dividend | ₹7.00 | ₹60.00 |
Last 12-Month Dividend Yield | 0.82% | 0.91% |
3-Year Avg Annual Dividend | ₹4.67 | ₹50.00 |
3-Year Avg Dividend Yield | 0.43% | 0.70% |
3-Year Total Dividends | ₹14.00 | ₹150.00 |
Ex-Dividend Date | Aug 06, 2025 | Jul 25, 2025 |